Liver cancer
Results
Phase 1/2
This trial looked at tefinostat for the most common type of liver cancer called hepatocellular carcinoma (HCC).
This trial was open for people to join between 2012 and 2017. The team reported the results in 2019.
Cancer Research UK supported this trial.
Recruitment start: 24 December 2012
Recruitment end: 11 May 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr David Propper
Cancer Research UK
Chroma Therapeutics
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Queen Mary University of London
This is Cancer Research UK trial number CRUKD/12/011.
Last reviewed: 28 September 2021
CRUK internal database number: 9047
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
